Revision: 1967_Sackson_361_December 07.jpg

HTML

Daniel Prieto Alhambra and colleagues at the Hospital del Mar, studied a cohort of 290 breast cancer patients undergoing treatment with Tamoxifen or another of the aromatase inhibitors AIs <a href=https://doxycycline.world/>doxycycline drug class</a>